Massachusetts Alzheimer's disease research center: progress and challenges
On September 19, 2014, the Massachusetts Alzheimer's Disease Research Center (ADRC)
held a daylong scientific symposium to celebrate 30 years of research productivity. It was a …
held a daylong scientific symposium to celebrate 30 years of research productivity. It was a …
The draft “National Plan” to address Alzheimer's disease-National Alzheimer's project act (NAPA)
ZS Khachaturian, AS Khachaturian, W Thies - Alzheimer's & Dementia, 2012 - Elsevier
This perspective updates the status of the “National Plan to Address Alzheimer's Disease”
and the recommendations of the NAPA Advisory Council's Sub-committee on Research …
and the recommendations of the NAPA Advisory Council's Sub-committee on Research …
Workgroup on NAPA's scientific agenda for a national initiative on Alzheimer's disease
Alzheimer's Association Expert Advisory … - Alzheimer's & …, 2012 - Wiley Online Library
This report outlines a goal‐directed scientific agenda for a national initiative to overcome the
Alzheimer's disease (AD) crisis. The statement, which reflects the collective views and …
Alzheimer's disease (AD) crisis. The statement, which reflects the collective views and …
The national Alzheimer's coordinating center (NACC) database: an Alzheimer disease database
DL Beekly, EM Ramos, G van Belle… - Alzheimer Disease & …, 2004 - journals.lww.com
Abstract The National Alzheimer's Coordinating Center (NACC) is responsible for
developing and maintaining a database of patient information collected from the 29 …
developing and maintaining a database of patient information collected from the 29 …
Past, present, and future directions for Alzheimer research
AC Hurley, N Wells - Alzheimer Disease & Associated Disorders, 1999 - journals.lww.com
To understand the current thinking and future research directions in Alzheimer disease (AD),
it is essential to examine the breadth of research into AD. AD was identified as a distinct …
it is essential to examine the breadth of research into AD. AD was identified as a distinct …
Eyes on the prize: Federal Alzheimer's research effort aims to facilitate interventions
RJ Hodes, N Buckholtz, V Cahan… - Alzheimer's & …, 2008 - Elsevier
The public Alzheimer's disease (AD) research enterprise began in earnest in the mid-1970s
with the creation by Congress of the National Institute on Aging at the National Institutes of …
with the creation by Congress of the National Institute on Aging at the National Institutes of …
[引用][C] Alzheimer's & Dementia: the Journal of the Alzheimer's Association
ZS Khachaturian - Alzheimer's & Dementia, 2008 - Wiley Online Library
Alzheimer's Association received acceptance for inclusion in MEDLINE, the bibliographic
database of the US National Library of Medicine (NLM). Three years since the launch, this …
database of the US National Library of Medicine (NLM). Three years since the launch, this …
Advances in Research and Treatment for Alzheimer's Disease
S Barrack - 2012 - books.google.com
Alzheimer's disease (AD), is the most common form of dementia. There is no cure for the
disease, which worsens as it progresses, and eventually leads to death. The cause and …
disease, which worsens as it progresses, and eventually leads to death. The cause and …
Two decades of research in Alzheimer disease: looking back to the first volume of ADAD
LF Jarvik, SS Matsuyama - Alzheimer Disease & Associated …, 2006 - journals.lww.com
During the first two decades of the life of this Journal (ADAD) much progress has been made
in our understanding of Alzheimer disease (AD). Advancing knowledge, however, has been …
in our understanding of Alzheimer disease (AD). Advancing knowledge, however, has been …
[PDF][PDF] Alzheimer's prevention initiative.
G Strobel - Journal of Alzheimer's Disease, 2010 - Citeseer
On 26 January 2010, at an ordinary airport hotel in Phoenix, Arizona, an extraordinary
gathering unfolded. High-level representatives of 19 different pharma, biotech, and medical …
gathering unfolded. High-level representatives of 19 different pharma, biotech, and medical …